Act early to help slow myopia progression.

SightGlass Vision™ spectacle lenses with Diffusion Optics Technology™ is a new and unique lens technology which reduces contrast to help slow axial elongation in myopia.9

Introducing NEW SightGlass Vision™ spectacle lenses powered by Diffusion Optics Technology™.

59% reduction

in myopia progression, on average, in children with full time wear over 2 years.12*

Become a SightGlass Vision™ practice

SightGlass Vision™ spectacles are designed to fit seamlessly into your practice.

Follow the training and learn more about how to apply SightGlass Vision™ in your practice.

Follow the training module

Follow the technical and clinical training now, become an expert and get your certificate.

More SightGlass Vision™

Product information of SightGlass Vision™ spectacle lenses powered by Diffusion Optics Technology™.

Myopia is rapidly increasing globally

Children are becoming myopic at an earlier age1
Presence of myopia increases the risk of future ocular complications2

Early intervention may slow the progression
of myopia in children5,6*

Our solutions

SightGlass Vision™

Een uniek brillenglas om de ontwikkeling van myopie bij kinderen vanaf 6 jaar te vertragen.
View product

MiSight® 1 day

Dé zachte kinderdaglens waarvan bewezen is dat die myopie bij kinderen afremt.
View product

DreamLite® MC nachtlenzen

Dé nachtlens waarvan bewezen is dat deze progressieve myopie bij kinderen remt.
View product

1. Holden BA, et al. Opthalmol. 2016;123:1036–42; 2. Flitcroft DI. Prog Retin Eye Res. 2012;31:622–660; 3. Németh J, et al. Eur J Ophthalmol. 2021;31(3):853–883; 4. Tideman J, et al. JAMA Ophthalmol. 2016;134(12):1355–1363; 5. Chamberlain P, et al. Clinical evaluation of a dual-focus myopia control 1 day soft contact lens: 6-year results (2020 American Academy of Optometry Annual Meeting); 6. Polling JR, et al. Br J Ophthalmol. 2021;0:1–5; 7. Rappon J, et al. Novel DOT Lenses from SightGlass Vision Show Great Promise to Fight Myopia. Review of Myopia Management. Available at: [Accessed Sep 2021]; 8. Rappon J, et al. Invest Ophthalmol Vis Sci. 2019;60(9):5845-5845; 9. Rappon J, et al. Optom Vis Sci. 2020;97:E-abstract 200036; 10. Morgan IG & Rose KA. Clin Exp Optom. 2019;102(1):3-17; 11. Greenwald SH, et al. Transl Vis Sci Technol. 2017;6(3); 12. SGV data on file 2021. Control of Myopia Using Peripheral Diffusion Lenses: Efficacy and Safety Study, 24-month results (n = 256, 14 North American sites).

Volg bij het adviseren van SGV brillenglazen bij kinderen jonger dan 8 jaar de opgestelde richtlijnen van het NOG, OVN en de NVVO op.